Effect of Topical Nepafenac in Macular Thickening Related to Pan-Retinal Photocoagulation
Status:
Unknown status
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether topical nepafenac (qid) is effective in
preventing and treating macular thickening related pan-retinal photocoagulation in patients
with diabetic retinopathy.